SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 641, doi. 10.1002/1878-0261.13564
- By:
- Publication type:
- Article
Works by Daley, Brianna
Results: 3
1
2
Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 2, p. e187754, doi. 10.1001/jamanetworkopen.2018.7754
- By:
- Publication type:
- Article
3
Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00905
- By:
- Publication type:
- Article